NCT02568527View on ClinicalTrials.gov

Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patients

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

July 31, 2018

Conditions
Limbal Stem Cell Deficiency
Interventions
DEVICE

PLGA scaffold

Poly-Lactic-co-Glycolic Acid (50:50) biodegradable, synthetic scaffold

Trial Locations (1)

500034

LV Prasad Eye Institute, Hyderabad

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

University of Sheffield

OTHER

lead

Virender S Sangwan, MBBS, MS

OTHER

NCT02568527 - Biodegradable Synthetic Scaffold as a Substitute for hAM in Limbal Epithelial Cells Transplant in LSCD Patients | Biotech Hunter | Biotech Hunter